"title: application value of ultrasonic scalpel in modified radical mastectomy and axillary lymph node dissection in patients with breast cancer.Author: haihui sheng.Citation: medical equipment (january 2021); vol.34, no.2: 64-65.Https://www.Cnki.Net.The aim of this study is to investigate the effect of ultrasonic scalpel in modified radical mastectomy and axillary lymphadenectomy in patients with breast cancer.From january 2017 to june 2020, a total of 70 patients with breast cancer admitted to haimen people's hospital were included in the study.These patients were randomly divided into experimental group (35 patients; mean age = 52.5 ± 2.3; age range = 30 to 84 years) and control group (35 patients; average age = 51.1 ± 1.6; age range = 30 to 84 years).The control group was treated with modified radical mastectomy and axillary lymphadenectomy with conventional electrocautery, while the experimental group was treated with modified radical mastectomy and axillary lymph node dissection assisted by ultrasonic scalpel (ethicon, model gen11).Reported complication includes flap necrosis (n=1).In conclusion, modified radical mastectomy and axillary lymphadenectomy with ultrasonic scalpel in breast cancer patients can achieve satisfactory results, and the incidence of postoperative complications is low." product: "ultrasonic scalpel (ethicon), gen 11 (ethicon)".Patient info: "ultrasonic scalpel (ethicon) and gen 11 (ethicon): flap necrosis (n=1)".Treatment noted: treatment for the events was not reported.Author: "haihui sheng.Haimen people's hospital (haimen, jiangsu province 226100)".
|
(b)(4).Date sent: 7/19/2021.Additional information was requested and the following was obtained: does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.¿¿no.Upon review of the information provided, it was concluded that this event does not meet the fda defined criteria for a reportable event and is being considered not reportable.
|